metanephrine has been researched along with Neurofibromatosis 1 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Dremlyuga, NV; Mezhinskaya, EM; Polyansky, EA; Ryabchenko, EV | 1 |
| Bechmann, N; Beuschlein, F; Calsina, B; Constantinescu, G; Deutschbein, T; Eisenhofer, G; Fankhauser, M; Fassnacht, M; Fliedner, S; Langton, K; Lenders, JWM; Monteagudo, M; Nölting, S; Pamporaki, C; Peitzsch, M; Prejbisz, A; Robledo, M; Stell, A; Timmers, HJLM | 1 |
| Hashimoto, H; Murakami, H; Nakamura, K; Sonoo, T | 1 |
| Aust, D; Därr, R; Eisenhofer, G; Gieldon, L; Hackmann, K; Januszewicz, A; Klink, B; Lahera, M; Masjkur, JR; Prejbisz, A; Richter, S; Robledo, M; Rump, A; Schrock, E; Tzschach, A; Zeugner, S | 1 |
| Graybill, S; Kim, J; Nguyen, B; Wan, W | 1 |
| Anastasi, E; Calvieri, S; Cianci, R; Cotesta, D; De Toma, G; Giustini, S; Letizia, C; Marinelli, C; Petramala, L; Schina, M; Sciomer, S; Zinnamosca, L | 1 |
| Pacak, K | 1 |
7 other study(ies) available for metanephrine and Neurofibromatosis 1
| Article | Year |
|---|---|
[Pheochromocytoma associated with primary hyperparathyroidism and type 1 neurofibromatosis].
Topics: Adrenal Gland Neoplasms; Female; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Neurofibromatosis 1; Paraganglioma; Parathyroid Neoplasms; Pheochromocytoma | 2023 |
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Dopamine; Female; Humans; Male; Metanephrine; Middle Aged; Mutation; Neurofibromatosis 1; Normetanephrine; Paraganglioma; Pheochromocytoma; Prospective Studies; Proto-Oncogenes; Risk Factors | 2020 |
Pheochromocytoma crisis in a patient with newly diagnosed neurofibromatosis type 1.
Topics: 3-Iodobenzylguanidine; Adrenalectomy; Alcoholism; Catecholamines; Chlorides; Humans; Hypokalemia; Hyponatremia; Hypophosphatemia; Male; Metanephrine; Middle Aged; Neurofibromatosis 1; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tachycardia, Ventricular; Water-Electrolyte Imbalance | 2021 |
Next-generation panel sequencing identifies
Topics: Adrenal Gland Neoplasms; Adult; Base Sequence; Carcinoma, Neuroendocrine; Codon, Nonsense; Epinephrine; Female; Genes, Neurofibromatosis 1; Genetic Predisposition to Disease; Germ-Line Mutation; High-Throughput Nucleotide Sequencing; Humans; Hypertension; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neurofibromatosis 1; Normetanephrine; Paraganglioma; Pedigree; Pheochromocytoma; Prostatic Neoplasms; Thyroid Neoplasms | 2018 |
Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-2 Receptor Agonists; Clonidine; False Positive Reactions; Female; Humans; Metanephrine; Middle Aged; Neurofibromatosis 1; Pheochromocytoma | 2019 |
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Cardiovascular System; Echocardiography; Female; Humans; Hypertension; Male; Metanephrine; Middle Aged; Neurofibromatosis 1; Pheochromocytoma; Prevalence; Vanilmandelic Acid | 2011 |
Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Topics: Adenosine Triphosphate; Adrenal Gland Neoplasms; Catecholamines; Humans; Metanephrine; Multiple Endocrine Neoplasia Type 2a; Mutation; Neurofibromatosis 1; Normetanephrine; Oxidative Stress; Paraganglioma; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Proto-Oncogene Mas; Receptors, Adrenergic; Succinate Dehydrogenase; von Hippel-Lindau Disease | 2011 |